BeOne Medicines Ltd.

ONC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$313.77-0.71%

2026-08-03

Financials

Valuation Metrics

BeOne Medicines Ltd.'s Market Cap is $32.55B. At end of 2025 it was $33.13B. Ranked #436 of 3,111 in US market (top 14%), #127 of 1,445 on NASDAQ (top 9%), #22 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 8%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$32.55B	US#436/3,111 Sec#22/269
Revenue	$5.74B	US#823/3,111 Sec#27/269
Net Income	$513M	US#804/3,111 Sec#30/269
Total Assets	$8.55B	US#1,079/3,111 Sec#32/269
Net Assets	$4.76B	US#722/3,111 Sec#30/269
Value
P/E	63.46x	US#1,963/3,111 Sec#63/269
P/B	6.84x	US#2,421/3,111 Sec#174/269
PEG	0.00x	US#10/3,111 Sec#3/269
P/S	5.67x	US#2,367/3,111 Sec#92/269
EV/EBITDA	32.06x	US#2,215/3,111 Sec#69/269
FCF Yield	2.60%	US#1,844/3,111 Sec#64/269
Profitability
ROE	10.78%	US#1,275/3,111 Sec#55/269
ROA	6.00%	US#863/3,111 Sec#50/269
Op. Margin	11.95%	US#1,470/3,111 Sec#60/269
Revenue Growth	35.46%	US#426/3,111 Sec#65/269
Earnings Growth	17802.13%	US#1/3,111 Sec#1/269
Financial Health
Debt Ratio	79.68%	US#881/3,111 Sec#159/269
Total Debt	$1.15B	US#1,434/3,111 Sec#41/269
FCF	$847M	US#638/3,111 Sec#27/269
Cash	$4.79B	US#207/3,111 Sec#13/269
Current Ratio	3.64x	US#633/3,111 Sec#175/269
Net Debt/EBITDA	-4.04x	US#92/3,111 Sec#4/269
Performance
1Y Return	4.94%	US#1,865/3,111 Sec#185/269
1M Return	5.42%	US#570/3,111 Sec#34/269
From 52W High	-18.55%	US#1,529/3,111 Sec#102/269
1Y MDD	-31.05%	US#1,464/3,111 Sec#91/269
Trading
Volume	357,717 shares	US#2,504/3,111 Sec#241/269
Trading Value	$112M	US#1,028/3,111 Sec#61/269
Per Share
EPS	$2.63	US#1,075/3,111 Sec#36/269
BPS	$39.99	US#593/3,111 Sec#13/269